Metoprolol Tartrate Tablets USP 50 mg

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight)

What was recalled

Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals LTD. Hinjwadi, Pune, India, Manufactured for TEVA Phamaceuticals USA, Sellersville, PA 18960, NDC 0093-0733-10

Recalling firm: Teva Pharmaceuticals USA, Inc.
NDC code: 0093-0733-10
Origin: PA, United States
Initiated by: Voluntary: Firm initiated
FDA recall number: D-1409-2012

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Metoprolol recalls

See all

Class II · Moderate risk Ongoing Apr 27, 2026